NCT01139099 The Evaluation of Therapeutic Efficacy on the Integrated Group Psychotherapy for Patients With Schizophrenia Status COMPLETED Phase NA
NCT01138618 Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ) Status COMPLETED Phase N/A
NCT01137799 The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients Status TERMINATED Phase PHASE1
NCT01136772 A Comparison of Long-acting Injectable Medications for Schizophrenia Status COMPLETED Phase PHASE4
NCT01133080 Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study Status UNKNOWN Phase PHASE4
NCT01129882 An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia Status COMPLETED Phase PHASE3
NCT01123317 Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia Status WITHDRAWN Phase NA
NCT01121042 Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron in Schizophrenia Status COMPLETED Phase PHASE3
NCT01116830 A Study of the Effect of RO4917838 on Biomarker Measures of Cognitive Dysfunction in Participants With Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase PHASE1
NCT01110317 A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate Status COMPLETED Phase PHASE1
NCT01104792 Long-term Study of Cariprazine in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01104766 Safety and Efficacy of Cariprazine in Patients With Schizophrenia Status COMPLETED Phase PHASE3